Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones

Leukemia

Volumn 18, Issue 8, 2004, Pages 1413-1419

  Ishii, Y ^a,b   Kiyota, H ^c   Sakai, S ^b   Honma, Y ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Differentiation; Differentiation therapy; Jasmonate; Myeloid leukemia; Plant hormone

Indexed keywords

1 NAPHTHYL ACETATE ESTERASE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTINEOPLASTIC AGENT; CALCITRIOL; COTYLENIN A; DIHYDROJASMONE; DIMETHYL SULFOXIDE; JASMONIC ACID; MEMBRANE ANTIGEN; METHYL 1,2 TRIFLUOROJASMONATE; METHYL 3,7 DIDEHYDROJASMONATE; METHYL 3,7 METHANOJASMONATE; METHYL 4,5 DIDEHYDROJASMONATE; METHYL 7 FLUOROEPIJASMONATE; METHYL 7 FLUOROJASMONATE; METHYLJASMONATE; METHYLJASMONATE ENOLACETATE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITROBLUE TETRAZOLIUM; PHYTOHORMONE; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL STRAIN HL 60; CELL STRUCTURE; CONTROLLED STUDY; DRUG INDICATION; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GRANULOCYTE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; MONOCYTE; MYELOID LEUKEMIA; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 4344686851     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403421     Document Type: Article

References (36)

1. Ishii Y, Hori Y, Sakai S, Honma Y. Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin ribosides, plant redifferentiation-inducing hormones. Cell Growth Differ 2002; 13: 19-26.
2. Honma Y. Cotylenin A - a plant growth regulator as a differentiation-inducing agent against myeloid leukemia. Leuk Lymph 2002; 43: 1169-1178.
3. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000; 69: 145-182.
4. Weber H. Fatty acid-derived signals in plants. TRENDS Plant Sci 2002; 7: 217-224.
5. Turner JG, Ellis C, Devoto A. The jasmonate signal pathway. Plant Cell 2002; 14 (Suppl): S153-S164.
6. Santoro MG, Benedetto A, Jaffe BM. Effect of endogenous and exogenous prostaglandin E on Friend erythroleukemia cell growth and differentiation. Br J Cancer 1979; 39: 259-267.
7. Honma Y, Kasukabe T, Hozumi M. Inhibition of differentiation of cultured mouse myeloid leukemia cells by nonsteroidal anti-inflammatory agents and counteraction of the inhibition by prostaglandin E. Cancer Res 1979; 39: 2190-2194.
8. Olsson IL, Breitman TR, Gallo RC. Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3′:5′-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor. Cancer Res 1982; 42: 3928-3933.
9. Fingrut O, Flescher E. Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells. Leukemia 2002; 16: 608-616.
10. 2+-ATPase affects contractile responses in rat slow-twitch skeletal muscle. J Pharm Exp Ther 2002; 300: 638-646.
11. Kiyota H, Saitoh M, Oritani T, Yoshihara T. Synthesis and potato tuber-inducing activity of methyl 5′,5′,5′-trifluorojasmonate. Phytochemistry 1996; 42: 1259-1262.
12. Kiyota H, Yoneta Y, Oritani T. Synthesis and biological activities of methyl 3,7- and 4,5-didehydrojasmonates. Phytochemistry 1997; 46: 983-986.
13. Kiyota H, Higashi F, Koike T, Oritani T. Lipase-catalyzed preparation of both enantiomers of methyl jasmonate. Tetrahedron-Asymmetr 2001; 12: 1035-1038.
14. Kiyota H, Koike T, Higashi F, Oritani T. Syntheses and odour descriptions of cyclopropanated compounds 2. Analogues of methyl jasmonate. Flavour Fragr J 2002; 17: 267-271.
15. Kiyota H, Takigawa S, Kuwahara S. Syntheses and odur descriptions of cyclopropanated compounds 5. Analogues of methyl jasmonate to fix the relative stereochemistry of the two side chains. Helv Chim Acta (in press).
16. Ishii Y, Sakai S, Honma Y. Pyridinyl imidasole inhibitor SB203580 activates p44/42 mitogen-activated protein kinase and induces the differentiation of human myeloid leukemia cells. Leuk Res 2001; 25: 813-820.
17. Dolbeare F, Selden JR. Immunochemical quantitation of bromodeoxyuridine: application to cell-cycle kinetics. Method Cell Biol 1994; 41: 297-316.
18. Makishima M, Okabe-Kado J, Honma Y. Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1α-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea. Br J Haematol 1998; 77: 33-39.
19. Honma Y, Takenaga K, Kasukabe T, Hozumi M. Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids. Biochem Biophys Res Commun 1980; 95: 507-512.
20. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa LJ et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-572.
21. Miyaura C, Abe E, Kuribayashi T, Tanaka H, Konno K, Nishii Y et al. 1,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 1981; 102: 937-943.
22. Gespach C, Saal F, Cost H, Abita JP. Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils. Mol Pharmacol 1982; 22: 547-553.
23. Tortora G, Tagliaferri P, Clair T, Colamonici O, Neckers LM, Robins RK et al. Site-selective cAMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic and acute lymphocytic human leukemia cell lines. Blood 1988; 71: 230-233.
24. Yen A, Roberson MS, Varvayanis S, Lee AT. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 1998; 58: 3163-3172.
25. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995; 92: 7686-7689.
26. Bertagnolo V, Neri LM, Marchisio M, Mischiati C, Capitani S. Phosphoinositide 3-kinase activity is essential for all-trans-retinoic acid-induced granulocytic differentiation of HL-60 cells. Cancer Res 1999; 59: 542-546.
27. Petersen M, Brodersen P, Naested H, Andreasson E, Lindhart U, Johansen B et al. Arabidopsis map kinase 4 negatively regulates systemic acquired resistance. Cell 2000; 103: 1111-1120.
28. Song F, Goodman RM. OsBIMK1, a rice MAP kinase gene involved in disease resistance responses. Planta 2002; 215: 997-1005.
29. Kumar D, Klessig DF. Differential induction of tobacco MAP kinases by the defense signals nitric oxide, salicylic acid, ethylene, and jasmonic acid. Mol Plant Microbe Interact 2000; 13: 347-351.
30. Honma Y, Ishii Y, Kasukabe T, Okabe-Kado J, Yamamoto-Yamaguchi Y, Kakegawa T et al. Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives. Exp Hematol 2001; 29: 194-201.
31. Rotem R, Fingrut O, Moskovitz J, Flescher E. The anticancer plant stress-protein methyl jasmonate induces activation of stress-regulated c-Jun N-terminal kinase and p38 protein kinase in human lymphoid cells. Leukemia 2003; 17: 2230-2256.
32. Pakkala S, Vos SD, Elstner E, Rude RK, Uskokovic M, Binderup L et al. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leuk Res 1995; 19: 65-72.
33. Vesly J, Havlicek L, Strnad M, Blow J, Donella-Deana A, Pinna L et al. Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem 1994; 224: 771-786.
34. Meijer L, Borgne A, Mulner O, Chong JPJ, Blow J, Inagaki N et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 1997; 243: 527-536.
35. Havlicek L, Hanus J, Vesely J, Leclerc S, Meijer L, Shaw G et al. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem 1997; 40: 408-412.
36. Vermeulen K, Strnad M, Krystof V, Havlicek L, Van der Aa A, Lenjou M et al. Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases. Leukemia 2002; 16: 299-305.